Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole in Infants with GERD
NCT00992589Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Johnson & Johnson. Started Nov 2009; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00992589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992589.